Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York Stock ...

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.

Wondering whether ResMed at around US$220 a share looks like a bargain or a potential value trap? This article walks through what the current price actually reflects about the business. The stock has ...

San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and ...

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at patient monitoring stocks, starting with ...

When Philips first began its massive recall of more than 5 million CPAP and BiPAP machines and other ventilators in mid-2021, its competitor ResMed swooped in to fill the void left behind—seemingly ...

I confess: I've been sleeping on ResMed (NYSE: RMD) stock, not paying much attention to it at all. But maybe I shouldn't ignore it -- and you may not want to, either. Here are three reasons why it's ...

For the past 18 months, ResMed Chief Executive Mick Farrell has been publicly outspoken in urging that medical devices get priority access to semiconductors amid global chip shortages coming out of ...

A recent survey by ResMed highlights increasing awareness among employees about the importance of sleep, while also ...

Shares of ResMed Inc. RMD rallied 1.25% to $233.50 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.25% to 6,716.09 and ...